Antimicrobial peptides (AMPs) are short peptidic molecules produced by most living
creatures. They help unicellular organisms to successfully compete for nutrients with other …

Bacterial infections caused by intracellular pathogens are difficult to control. Conventional
antibiotic therapies are often ineffective, as high doses are needed to increase the number …

Antimicrobials, and particularly antimicrobial peptides (AMPs), have been thoroughly
studied due to their therapeutic potential. The research on their exact mode of action on …

Antibiotic therapy failure is often caused by the presence of persister cells, which are
metabolically-dormant bacteria capable of surviving exposure to antimicrobials. Under …

Biofilm formation is a common strategy used by bacteria in order to survive and persist in the
environment. In Vibrio cholerae (V. cholerae), a Gram-negative pathogen responsible for the …

Staphylococcus aureus is a common cause of both superficial and invasive infections of
humans and animals. Despite a potent host response and apparently appropriate antibiotic …

Insect defensins are promising candidates for the development of potent antimicrobials
against antibiotic-resistant Staphylococcus aureus (S. aureus). An insect defensin, DLP4 …

Antimicrobial resistance in livestock: antimicrobial peptides provide a new solution for a
growing challenge | Animal Frontiers | Oxford Academic Skip to Main Content …

Natural peptides with antimicrobial activity are extremely diverse, and peptide synthesis
technologies make it possible to significantly improve their properties for specific tasks …

A major global public health concern is antimicrobial resistance (AMR). Antimicrobial
peptides (AMPs) are a potentially appropriate replacement for conventional antibiotics. The …